共 39 条
[1]
Kauppinen-Makelin R(2005)A nationwide survey of mortality in acromegaly J Clin Endocrinol Metab 90 4081-4086
[2]
Ben-Shlomo A(2010)Pituitary gland: predictors of acromegaly-associated mortality Nat Rev Endocrinol 6 67-69
[3]
Melmed S(2018)A Consensus Statement on acromegaly therapeutic outcomes Nat Rev Endocrinol 14 552-561
[4]
Katznelson L(2014)Acromegaly: an endocrine society clinical practice guideline J Clin Endocrinol Metab 99 3933-3951
[5]
Ayuk J(2004)Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly J Clin Endocrinol Metab 89 1613-1617
[6]
Molitch ME(2017)Diagnosis and treatment of pituitary adenomas: a review JAMA 317 516-524
[7]
Sims-Williams HP(2019)Radiosurgery as primary management for acromegaly Clin Endocrinol 90 114-121
[8]
Sherlock M(2009)ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly J Clin Endocrinol Metab 94 4216-4223
[9]
Castinetti F(2009)Radiotherapy and radiosurgery in acromegaly Pituitary 12 3-10
[10]
Gheorghiu ML(2017)Updates in outcomes of stereotactic radiation therapy in acromegaly Pituitary 20 154-168